What is nephrotic syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Nephrotic Syndrome

Nephrotic syndrome is a clinical syndrome defined by heavy proteinuria (≥3.5 g/day in adults or ≥1.0 g/m²/day in children), hypoalbuminemia (<3.0 g/dL in adults or <2.5 g/dL in children), and edema, commonly accompanied by hypercholesterolemia 1.

Core Diagnostic Criteria

The syndrome represents a pathophysiological state of increased glomerular permeability to macromolecules, resulting in massive urinary protein loss 1. The defining features are:

  • Proteinuria: >3.5 g/day in adults (>40 mg/m²/hour in children)
  • Hypoalbuminemia: Serum albumin <3.0 g/dL in adults (<2.5 g/dL in children)
  • Edema: Oncotic edema due to low plasma oncotic pressure
  • Hyperlipidemia: Commonly present but not required for diagnosis

Underlying Pathology

Nephrotic syndrome develops from pathological injury to renal glomeruli, specifically podocyte damage that disrupts the glomerular filtration barrier 1, 2. This can be:

Primary (Idiopathic): The three leading histologic variants are 1:

  • Minimal change disease (MCD) - most common in children
  • Focal segmental glomerulosclerosis (FSGS) - most common in populations of African ancestry
  • Membranous nephropathy - most common in white adults

Secondary: Systemic diseases including diabetes mellitus (most common), systemic lupus erythematosus, amyloidosis, malignancy, infections, and medications 2, 3.

Clinical Presentation

Patients typically present with 2:

  • Periorbital edema (most noticeable in the morning)
  • Dependent pitting edema (more common later in the day)
  • Frothy urine from heavy proteinuria

Critical Complications Affecting Morbidity and Mortality

The syndrome carries significant morbidity and mortality risk through multiple mechanisms 1:

Thromboembolism: Patients have markedly increased risk with prevalence of:

  • Renal vein thrombosis: 29%
  • Pulmonary embolism: 17-28%
  • Deep vein thrombosis: 11%

Cardiovascular disease: Risk of coronary heart disease is four times greater than age-matched controls due to hypercholesterolemia, hypertension, hypercoagulability, and steroid exposure 1.

Infections: Particularly in children - cellulitis and spontaneous bacterial peritonitis due to immunoglobulin loss and immunosuppression 1.

Kidney failure: Proteinuria >3.8 g/day confers 35% risk of end-stage renal disease within 2 years, compared to only 4% risk with proteinuria <2.0 g/day 1.

Hypoalbuminemia impact: Each 1.0 g/dL decrease in serum albumin increases odds of morbidity by 89% and mortality by 137% 1.

Pathophysiological Mechanism

The exact pathogenesis remains incompletely understood but involves 1, 4:

  • Complex interplay of immune dysfunction
  • Circulating permeability factors (possibly T-cell-driven lymphokines)
  • Direct podocyte injury
  • Genetic factors in some cases
  • In membranous nephropathy, autoantibodies against podocyte antigens may be detected 3

Clinical Course

Nephrotic syndrome often follows a relapsing-remitting course, with a subset of patients continuing to experience relapses into adulthood 4. The duration and severity of proteinuria are surrogate markers for disease progression, making proteinuria reduction the primary therapeutic target to prevent renal scarring and failure 1.

References

Research

[Nephrotic syndrome].

Innere Medizin (Heidelberg, Germany), 2025

Research

Nephrotic Syndrome: Current Management.

Indian journal of pediatrics, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.